Navigation Links
American Oriental Bioengineering Announces Participation in November Investor Conferences
Date:10/31/2008

NEW YORK, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB) ("AOBO"), a leading marketer, distributor and manufacturer of pharmaceutical and healthcare products in China, today announced that the Company will present at the following conferences:

-- Oppenheimer 19th Annual Healthcare Conference, held at the Waldorf-

Astoria in New York. Management is currently scheduled to present at

8:40 am ET on Tuesday, November 4, 2008.

-- Credit Suisse Asia Healthcare Conference, held at the Westin in Beijing.

Management is currently scheduled to present at 4:30 pm local time on

Wednesday, November 5, 2008;

-- Morgan Stanley 2008 Asia Pacific Summit, held at the Mandarin Oriental

in Singapore. Management is currently scheduled to present at 3:15 pm

local time on Wednesday, November 12, 2008;

-- Oppenheimer 4th Annual 'Best Ideas' Conference, held at the Millennium

Broadway in New York. Management is currently scheduled to present at

1:20 pm ET on Tuesday, November 18, 2008. A webcast of this

presentation will be available via the Company's website at

http://www.bioaobo.com .

-- Lazard 5th Annual Healthcare Conference, held at the St. Regis in New

York. Management is currently scheduled to present at 11:30 am ET on

Wednesday, November 19, 2008.

For more details on the conferences, please contact your respective institutional sales representative.

About American Oriental Bioengineering Inc.

American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-Q for the quarter ended June 30, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.


'/>"/>
SOURCE American Oriental Bioengineering Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... ... July 17, 2017 , ... ... long-standing innovation strategy. A website (openinnovation.pioneer.com) dedicated to connecting third-party innovators ... – trait discovery, plant breeding, enabling technologies, biologicals and digital solutions. , “DuPont ...
(Date:7/16/2017)... PARSIPPANY, N.J. (PRWEB) , ... July 16, 2017 ... ... products, laboratory equipment and analytical instruments announced the launch of its new line ... shakers are ideal for applications that require CO2 and humidity for optimal cell ...
(Date:7/14/2017)... ... July 14, 2017 , ... Sonic Manufacturing ... Manufacturing Technologies has installed a solar system on its roof top. “We will ... President of Sonic, Kenneth Raab stated. The company’s proud history of social responsibility ...
(Date:7/14/2017)... ... 13, 2017 , ... LGC Maine Standards announces ... FDA 510 (k) clearance for use on Siemens Sysmex® CS-2500 System analyzers. The ... kit, prepared using the CLSI EP06-A “equal delta” sample preparation, offers five distinct ...
Breaking Biology Technology:
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):